Table 1 Characteristics of patients with community acquired Clostridium difficile infection (CA-CDI) and matched controls
Cases (n = 58) | Controls (n = 58) | p-value | ||||
|---|---|---|---|---|---|---|
Age (in years) | Mean (SD) | 62.1 | (19.2) | 62.2 | (19.7) | 0.99 |
Female | n (%) | 38 | (65.5) | 38 | (65.5) | 1.00 |
Caucasian Race | n (%) | 49 | (84.5) | 49 | (84.5) | 1.00 |
Charlson Index | Mean (SD) | 6.19 | (4.16) | 1.33 | (1.63) | < 0.01 |
Antibiotic Use | n (%) | 45 | (77.6) | 14 | (24.1) | < 0.01 |
Statin Use | n (%) | 18 | (31.0) | 7 | (12.1) | 0.013 |
PPI Use | n (%) | 33 | (56.9) | 6 | (10.3) | < 0.01 |
Supplement vitamin D use | n (%) | 22 | (37.9) | 10 | (17.2) | 0.013 |
Multivitamin Use | n (%) | 17 | (29.3) | 3 | (5.2) | 0.001 |
Baseline Albumin (g/dL) | Mean (SD) | 3.21 | (0.77) | 4.30 | (0.57) | < 0.01 |
Baseline Creatinine (mg/dL) | Mean (SD) | 2.37 | (6.74) | 0.95 | (0.37) | 0.12 |
Plasma 25(OH) D (ng/mL) | Mean (SD) | 28.5 | (15.4) | 33.8 | (12.8) | 0.04 |